HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Medullary thyroid carcinoma: prognosis of familial versus nonfamilial disease and the role of radiotherapy.

Abstract
A retrospective study of 202 patients with medullary thyroid carcinoma (MTC) diagnosed between 1943 and 1987 was done to compare the prognosis of patients with sporadic disease and those with the familial form of multiple endocrine neoplasia type II (MEN-II) and to study the effect of radiotherapy. The relationship between serum calcitonin (iCT), carcinoembryonic antigen (CEA), and calcitonin gene-related peptide (CGRP) to the extent of disease and prognosis was also studied. Patients with MEN-II had significantly longer survival rates than did patients with the sporadic variety (P less than 0.005), but most patients with sporadic disease were older and had more advanced disease. No differences in survival rates were found when patients from these two groups were matched for age and extent of disease (P greater than 0.7). When patients who received radiotherapy were matched for age, extent of disease, and surgery with patients who had had no radiotherapy, the latter group was found to live significantly longer (P less than 0.05). Our studies suggested (1) that the apparently poor prognosis of patients with sporadic MTC may be related to the patients' older age at detection rather than to inherent differences in the two forms of disease, (2) radiotherapy has little effect on MTC, (3) calcitonin gene-related peptide measurement was not helpful in determining the extent of disease or prognosis, (4) patients with liver metastasis had the highest iCT levels, (5) patients with bone metastasis had the highest CEA levels, and (6) patients with diarrhea had poor prognosis and had high iCT levels.
AuthorsN A Samaan, P N Schultz, R C Hickey
JournalHormone and metabolic research. Supplement series (Horm Metab Res Suppl) Vol. 21 Pg. 21-5 ( 1989) ISSN: 0170-5903 [Print] Germany
PMID2807151 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Carcinoembryonic Antigen
  • Calcitonin
  • Calcitonin Gene-Related Peptide
Topics
  • Adolescent
  • Adult
  • Calcitonin (blood)
  • Calcitonin Gene-Related Peptide (blood)
  • Carcinoembryonic Antigen (blood)
  • Carcinoma (mortality, pathology, radiotherapy)
  • Diarrhea (blood)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prognosis
  • Thyroid Neoplasms (mortality, pathology, radiotherapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: